WHO ICTRP trial
Effect of Yogurt Fortified with beta-Hydroxy beta-Methyl Butyrate (HMB) in…
IRCT20171223038017N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20171223038017N1 |
|---|---|
| Public title | Effect of Yogurt Fortified with beta-Hydroxy beta-Methyl Butyrate (HMB) in Sarcopenic Elderly |
| Scientific title | Evaluating the Effect of Yogurt Fortified with beta-Hydroxy beta-Methyl Butyrate (HMB), Vitamin D, and Vitamin C on Fat-Free Mass, Muscle Strength, and Physical Functionality in Sarcopenic Elderly |
| Primary sponsor | Shiraz University of Medical Sciences |
| Secondary sponsors | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Sarcopenia. Sarcopenia;M62.84;Sarcopenia |
| Interventions | Intervention 1: Intervention group: receiving 400 grams per day of yogurt fortified with beta-hydroxy beta-butyl butyrate (HMB), vitamin D, and C for 12-week intervention that were produced by Zarrin Ghazal Industrial Co. (Daity)… |
| Registration date | Jan 9, 2018 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: